Clark Y. Lin Attorney
Associate at Wilson Sonsini Goodrich & Rosati
Boston, US
c...@...sgr.com (Login to view more)
Practice Areas: Patent Litigation, Patent Prosecution...
(617) ???-???? (Login to view more)PatentsSubscription-Only
57
Patents (All Time)
40
Patents (Past 5 Years)
N/A
Applications (Past 5 Years)
Patents Counts by Examiners

Patents Distribution by IPC

Patents Counts by Companies

Office Actions/Extensions by Year

Issued/Abandoned by Year

Percentage of Foreign Originated Patents by Year

Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
17150587 | Enalapril formulations | A61K | Jan 14, 2021 | Jun 21, 2021 |
17133415 | Suspensions and diluents for metronidazole and baclofen | A61K, A61P | Dec 22, 2020 | May 9, 2022 |
16991575 | Enalapril formulations | A61K | Aug 11, 2020 | Feb 15, 2021 |
16883553 | Enalapril formulations | A61K | May 25, 2020 | Oct 12, 2020 |
16853380 | Amlodipine formulations | A01N, A61K | Apr 19, 2020 | Jan 18, 2021 |
16564904 | LISINOPRIL FORMULATIONS | A61K | Sep 8, 2019 | May 25, 2021 |
16381575 | Amlodipine formulations | A61K | Apr 10, 2019 | Oct 12, 2020 |
16295482 | Lisinopril formulations | A61K | Mar 6, 2019 | Sep 9, 2019 |
16242898 | Enalapril formulations | A61K | Jan 7, 2019 | Sep 14, 2020 |
62780890 | METHODS OF SUBSTITUTING PATHOGENIC AMINO ACIDS USING PROGRAMMABLE BASE EDITOR SYSTEMS | Dec 16, 2018 | ||
16177159 | Enalapril formulations | A61K | Oct 30, 2018 | Sep 28, 2020 |
16174157 | BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT | A61K, C12N, C07K | Oct 28, 2018 | Apr 9, 2021 |
16174177 | BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT | A61K, C07K | Oct 28, 2018 | Apr 13, 2021 |
16161986 | Single domain serum albumin binding protein | C07K, A61K | Oct 15, 2018 | Sep 26, 2022 |
62745247 | CD33xCD3 BINDING PROTEINS FOR TREATING INFLAMMATORY CONDITIONS AND DISEASES | Oct 11, 2018 | ||
16159545 | B cell maturation antigen binding proteins | A61P, A61K, C07K | Oct 11, 2018 | Feb 22, 2021 |
62734952 | CONDITIONALLY ACTIVE RECEPTORS | Sep 20, 2018 | ||
62733443 | CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE | Sep 18, 2018 | ||
62733444 | CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE | Sep 18, 2018 | ||
62733435 | CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE | Sep 18, 2018 |